http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20191655-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2013-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da50f3350d7dbd228d269fc463a4daae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2df538dfd9ff6e76ee2eb73996e0a483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f98bfbf4d3a1c9a5f11ce41d85bf0dec
publicationDate 2019-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20191655-A1
titleOfInvention PHARMACEUTICAL COMBINATIONS
abstract Referring to pharmaceutical combinations comprising: (a) a B-Raf kinase inhibitor of formula (Compound A) or its pharmaceutically acceptable salt; (b) an epidermal growth factor receptor (EGFR) inhibitor, wherein this inhibitor is cetuximab or erlotinib; and optionally (c) a phosphatidyl-inositol-3 kinase inhibitor (PI3Ka) of formula (Compound B), or a pharmaceutically acceptable salt. It also refers to its use in the treatment of proliferative diseases.
priorityDate 2012-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1956
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396494
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04412
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID463415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407319186
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13649
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24329
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404306
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37455
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870

Total number of triples: 37.